Cannabis News

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Aphria Inc. (NASDAQ: APHA) breached their fiduciary duties or violated the federal securities laws in connection with the company's merger with Tilray, Inc. (NASDAQ: TLRY)

Click here to learn more and participate in the action.

On December 16, 2020, Aphria announced that it had signed an agreement to be acquired by Tilray in an all-stock transaction. Pursuant to the merger agreement, Aphria stockholders will receive 0.8381 shares of Tilray common stock for each share of Aphria common stock owned. The deal is scheduled to close in the second quarter of 2021.

Bragar Eagel & Squire is concerned that Aphria's board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Aphria's stockholders.

If you own shares of Aphria and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at investigations@bespc.com or telephone at (212) 355-4648, or by filling out this contact form . There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com . Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:
Bragar Eagel & Squire, P.C.
Melissa Fortunato, Esq.
Alexandra Raymond, Esq.
investigations@bespc.com
www.bespc.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Cannabis Weekly Round-Up: Tilray Jumps Thanks to Latest Fiscal Results

Cannabis Weekly Round-Up: Tilray Jumps Thanks to Latest Fiscal Results

Shares of Tilray Brands (NASDAQ:TLRY,TSX:TLRY) jumped this week after the company released results for its fourth fiscal quarter and full 2022 year.

Also this past week, a Canadian cannabis producer announced a share consolidation plan.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Curaleaf Celebrates Opening Of Tampa Citrus Park Dispensary

The Company's retail presence grows to 51 locations in the Sunshine State and 137 nationwide

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announced today the opening of its Tampa Citrus Park dispensary, located at 10612 Sheldon Road, Tampa, FL 33626. Curaleaf Tampa Citrus Park expands the Company's retail presence to six locations in Hillsborough County and 51 across the Sunshine State.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

CANOPY GROWTH ANNOUNCES NEW PREMIUM FLOWER LINE-UP PERFECT FOR SUMMER STAYCATIONS AND WEEKENDS AWAY

New premium flower offerings from 7ACRES and Doja drop in retail locations this summer

 Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis and cannabinoid-based consumer product company, today announced several new additions to its premium flower portfolio. Perfect for both staycations and weekends away, the new premium flower offerings from 7ACRES and Doja demonstrate Canopy Growth's commitment to continued innovation and strengthen its leading position in the premium flower category.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Bada Bing! The Apothecarium Lodi is Now Open!

Patients and Consumers can now experience the convenience of New Jersey's first Dispensary Drive-Thru

TerrAscend Corp. (" TerrAscend " or the "Company") ( CSE : TER ) (OTCQX: TRSSF ), a leading North American cannabis operator, today announced the opening of The Apothecarium Lodi the Company's third retail location in New Jersey and 27 th overall. The dispensary began medical and adult-use sales today.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Curaleaf Launches Plant Precision, New Product Line Targeting Specific Health and Wellness Categories

Plant Precision fills consumer demand for low dose THC formats that are geared towards everyday wellness as 75% of Americans would consider using cannabis for health and wellness purposes*

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the launch of Plant Precision, a curated collection of edibles and a topical gel designed to target specific wellness categories.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
closeup of congress building on dollar bill

Cannabis Weekly Round-Up: New US Cannabis Bill Arrives, Path Forward Uncertain

A new piece of legislation geared at federal cannabis reform was introduced in the US Senate this week. However, experts aren’t confident that it will be approved by Congress.

Investors also saw a top analyst change their perspective on some cannabis companies in Canada.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Latest Press Releases

Related News

×